Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LUQMAN SEIDU

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1831129261
CMS profile
264843
Location
ATLANTA, GA

General Payments · PY2018–2024

$29,744.04

  • Reported across 280 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,835.19

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,822.85 44
PY2019 $1,657.02 34
PY2020 $2,238.33 35
PY2021 $5,774.12 44
PY2022 $8,471.07 47
PY2023 $945.46 39
PY2024 $5,835.19 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ALK-Abello, Inc $20.90 01/31/2024 Food and Beverage Undisputed 01/23/2026 1099895107 CMS
ALK-Abello, Inc $21.54 10/30/2024 Food and Beverage Undisputed 01/23/2026 1099895109 CMS
AstraZeneca Pharmaceuticals LP $23.16 06/18/2024 Food and Beverage Undisputed 01/23/2026 1105475277 CMS
AstraZeneca Pharmaceuticals LP $23.90 10/03/2024 Food and Beverage Undisputed 01/23/2026 1105556524 CMS
AstraZeneca Pharmaceuticals LP $26.75 10/23/2024 Food and Beverage Undisputed 01/23/2026 1105740960 CMS
BioCryst US Sales Co., LLC $22.76 05/09/2024 Food and Beverage Undisputed 01/23/2026 1117471524 CMS
BioCryst US Sales Co., LLC $19.53 06/27/2024 Food and Beverage Undisputed 01/23/2026 1117470672 CMS
Dermavant Sciences, Inc. $20.82 08/29/2024 Food and Beverage Undisputed 01/23/2026 1127930700 CMS
Dermavant Sciences, Inc. $20.63 12/19/2024 Food and Beverage Undisputed 01/23/2026 1127930704 CMS
Genentech USA, Inc. $74.77 03/13/2024 Food and Beverage Undisputed 01/23/2026 1133057201 CMS
Genentech USA, Inc. $20.84 05/02/2024 Food and Beverage Undisputed 01/23/2026 1133057189 CMS
Genentech USA, Inc. $20.95 07/24/2024 Food and Beverage Undisputed 01/23/2026 1133057193 CMS
Genentech USA, Inc. $91.15 11/26/2024 Food and Beverage Undisputed 01/23/2026 1133057197 CMS
GENZYME CORPORATION $21.82 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139737246 CMS
GENZYME CORPORATION $40.59 04/04/2024 Food and Beverage Undisputed 01/23/2026 1139737258 CMS
GENZYME CORPORATION $4.12 04/17/2024 Food and Beverage Undisputed 01/23/2026 1139737254 CMS
GENZYME CORPORATION $5.66 04/29/2024 Food and Beverage Undisputed 01/23/2026 1139737260 CMS
GENZYME CORPORATION $36.13 05/09/2024 Food and Beverage Undisputed 01/23/2026 1139737268 CMS
GENZYME CORPORATION $9.76 05/22/2024 Food and Beverage Undisputed 01/23/2026 1139737270 CMS
GENZYME CORPORATION $8.63 05/29/2024 Food and Beverage Undisputed 01/23/2026 1139737276 CMS
GENZYME CORPORATION $42.90 06/12/2024 Food and Beverage Undisputed 01/23/2026 1139737274 CMS
GENZYME CORPORATION $5.93 06/25/2024 Food and Beverage Undisputed 01/23/2026 1139737278 CMS
GENZYME CORPORATION $52.50 09/04/2024 Food and Beverage Undisputed 01/23/2026 1139737320 CMS
GENZYME CORPORATION $6.29 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139737324 CMS
GENZYME CORPORATION $38.59 12/18/2024 Food and Beverage Undisputed 01/23/2026 1139737346 CMS
GlaxoSmithKline, LLC. $21.50 05/16/2024 Food and Beverage Undisputed 01/23/2026 1116718605 CMS
GlaxoSmithKline, LLC. $15.78 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116663115 CMS
kaleo, Inc. $1,425.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1126627509 CMS
kaleo, Inc. $121.82 04/02/2024 Food and Beverage Undisputed 01/23/2026 1126627513 CMS
kaleo, Inc. $1,662.50 06/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1126627507 CMS
kaleo, Inc. $121.82 06/11/2024 Food and Beverage Undisputed 01/23/2026 1126627511 CMS
kaleo, Inc. $1,662.50 09/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1126627505 CMS
PFIZER INC. $15.44 04/12/2024 Food and Beverage Undisputed 01/23/2026 1131398795 CMS
Pharming Healthcare, Inc. $29.77 12/10/2024 Food and Beverage Undisputed 01/23/2026 1132165010 CMS
Regeneron Healthcare Solutions, Inc. $25.19 08/07/2024 Food and Beverage Undisputed 01/23/2026 1114165919 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.15 03/14/2024 Food and Beverage Undisputed 01/23/2026 1137671354 CMS
Takeda Pharmaceuticals U.S.A., Inc. $32.10 07/18/2024 Food and Beverage Undisputed 01/23/2026 1137671356 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.